Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Humbert

Showing results (371-380 of 958) with videos related to

Pageof 96
Sort By:
Chest|November 28, 2014
T-helper 17 cell polarization in pulmonary arterial hypertensionAurélie Hautefort, Barbara Girerd, David Montani, et al.
Expert Opinion on Drug Metabolism & Toxicology|November 17, 2010
Pharmacokinetic evaluation of continuous intravenous epoprostenolMarie-Camille Chaumais, Marion Jobard, Alice Huertas, et al.
Circulation Research|April 3, 2004
Serotonin-induced smooth muscle hyperplasia in various forms of human pulmonary hypertensionElisabeth Marcos, Elie Fadel, Olivier Sanchez, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 15, 2009
Dichloroacetate treatment partially regresses established pulmonary hypertension in mice with SM22alpha-targeted overexpression of the serotonin transporterChristophe Guignabert, Ly Tu, Mohamed Izikki, et al.
Nature Reviews. Disease Primers|January 4, 2024
Pulmonary hypertensionAna Mocumbi, Marc Humbert, Anita Saxena, et al.
American Journal of Respiratory Cell and Molecular Biology|November 2, 2010
Autocrine fibroblast growth factor-2 signaling contributes to altered endothelial phenotype in pulmonary hypertensionLy Tu, Laurence Dewachter, Benoit Gore, et al.
International Journal of Molecular Sciences|October 17, 2018
Ion Channels in Pulmonary Hypertension: A Therapeutic Interest?Mélanie Lambert, Véronique Capuano, Andrea Olschewski, et al.
British Journal of Clinical Pharmacology|June 9, 2022
Identifying new drugs associated with pulmonary arterial hypertension: A WHO pharmacovigilance database disproportionality analysisAlex Hlavaty, Matthieu Roustit, David Montani, et al.
Chest|October 7, 2015
ResponseAurélie Hautefort, Barbara Girerd, David Montani, et al.
Chest|June 7, 2016
Riociguat: Mode of Action and Clinical Development in Pulmonary HypertensionHossein-Ardeschir Ghofrani, Marc Humbert, David Langleben, et al.
Pageof 96

Showing results (371-380 of 958) with videos related to

Sort By:
Pageof 96
Chest|November 28, 2014
T-helper 17 cell polarization in pulmonary arterial hypertensionAurélie Hautefort, Barbara Girerd, David Montani, et al.
Expert Opinion on Drug Metabolism & Toxicology|November 17, 2010
Pharmacokinetic evaluation of continuous intravenous epoprostenolMarie-Camille Chaumais, Marion Jobard, Alice Huertas, et al.
Circulation Research|April 3, 2004
Serotonin-induced smooth muscle hyperplasia in various forms of human pulmonary hypertensionElisabeth Marcos, Elie Fadel, Olivier Sanchez, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 15, 2009
Dichloroacetate treatment partially regresses established pulmonary hypertension in mice with SM22alpha-targeted overexpression of the serotonin transporterChristophe Guignabert, Ly Tu, Mohamed Izikki, et al.
Nature Reviews. Disease Primers|January 4, 2024
Pulmonary hypertensionAna Mocumbi, Marc Humbert, Anita Saxena, et al.
American Journal of Respiratory Cell and Molecular Biology|November 2, 2010
Autocrine fibroblast growth factor-2 signaling contributes to altered endothelial phenotype in pulmonary hypertensionLy Tu, Laurence Dewachter, Benoit Gore, et al.
International Journal of Molecular Sciences|October 17, 2018
Ion Channels in Pulmonary Hypertension: A Therapeutic Interest?Mélanie Lambert, Véronique Capuano, Andrea Olschewski, et al.
British Journal of Clinical Pharmacology|June 9, 2022
Identifying new drugs associated with pulmonary arterial hypertension: A WHO pharmacovigilance database disproportionality analysisAlex Hlavaty, Matthieu Roustit, David Montani, et al.
Chest|October 7, 2015
ResponseAurélie Hautefort, Barbara Girerd, David Montani, et al.
Chest|June 7, 2016
Riociguat: Mode of Action and Clinical Development in Pulmonary HypertensionHossein-Ardeschir Ghofrani, Marc Humbert, David Langleben, et al.
Pageof 96